Financhill
Back

Spero Therapeutics Stock Price Chart

Sell
43

SPRO
Spero Therapeutics

Last Price:
1.59
Seasonality Move:
-16.99%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SPRO is experiencing slight buying pressure.

Spero Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 1.63 Sell
20-day SMA: 1.56 Buy
50-day SMA: 1.63 Sell
200-day SMA: 1.41 Buy
8-day EMA: 1.61 Sell
20-day EMA: 1.6 Sell
50-day EMA: 1.59 Sell
200-day EMA: 1.56 Buy

Spero Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 49.58 Sell
Chaikin Money Flow: 105065 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.44 - 1.64) Buy
Bollinger Bands (100): (1.45 - 1.69) Buy

Spero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Spero Therapeutics Stock

Is Spero Therapeutics Stock a Buy?

SPRO Technical Analysis vs Fundamental Analysis

Sell
43
Spero Therapeutics (SPRO) is a Sell

Is Spero Therapeutics a Buy or a Sell?

Spero Therapeutics Stock Info

Market Cap:
85.84M
Price in USD:
1.59
Share Volume:
178.26K

Spero Therapeutics 52-Week Range

52-Week High:
1.94
52-Week Low:
0.99
Sell
43
Spero Therapeutics (SPRO) is a Sell

Spero Therapeutics Share Price Forecast

Is Spero Therapeutics Stock a Buy?

  • Spero Therapeutics share price is 1.59 while SPRO 8-day exponential moving average is 1.61, which is a Sell signal.
  • The stock price of SPRO is 1.59 while Spero Therapeutics 20-day EMA is 1.60, which makes it a Sell.
  • Spero Therapeutics 50-day exponential moving average is 1.59 while SPRO share price is 1.59, making it a Sell technically.
  • SPRO stock price is 1.59 and Spero Therapeutics 200-day simple moving average is 1.56, creating a Buy signal.

Fundamental Analysis of Spero Therapeutics

Is Spero Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.33 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.53 per share, and an increase next year of $0.02 per share.

Technical Analysis of Spero Therapeutics

Should I short Spero Therapeutics stock?

* Spero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.